Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Schistosomiasis drugs: an ICPEMC study.

Progress in clinical and biological research - 1 Jan 1990

Kramers P G, Gentile J M, Gryseels B J, Jordan P, Katz N, Mott K E, Mulvihill J J, Seed J L, Frohberg H

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epidemiologic Methods
Share to International Cooperation
Share to Mutagens
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 2203034

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Schistosomiasis drugs: an ICPEMC study.PMID 2203034Read ↗

Artemisitene protected against murine schistosomiasis japonica through anti-parasite activity and immune regulationSemantic proximity Read ↗

Development of cysteine protease inhibitors as chemotherapy for parasitic diseases: insights on safety, target validation, and mechanism of actionSemantic proximity Read ↗

<i>In silico</i> Repositioning of Approved Drugs Against <i>Schistosoma mansoni</i> Energy Metabolism TargetsSemantic proximity Read ↗

Schistosome ABC multidrug transporters: From pharmacology to physiologySemantic proximity Read ↗

Multi-center screening of the Pathogen Box collection for schistosomiasis drug discovery.Semantic proximity Read ↗

Dual Strategy to Design New Agents Targeting Schistosoma mansoni: Advancing Phenotypic and SmCB1 Inhibitors for Improved Efficacy.Semantic proximity Read ↗

Drugging the Schistosome Zinc-Dependent HDACs: Current Progress and Future PerspectivesSemantic proximity Read ↗

Drug screening and development cascade for Chagas disease: an update of in vitro and in vivo experimental models.Semantic proximity Read ↗

Screening and Phenotypical Characterization of Schistosoma mansoni Histone Deacetylase 8 (SmHDAC8) Inhibitors as Multistage Antischistosomal Agents.Semantic proximity Read ↗

Rational approach to drug discovery for human schistosomiasisSemantic proximity Read ↗

Pharmacology and potential physiological significance of schistosome multidrug resistance transportersSemantic proximity Read ↗

Female genital schistosomiasis (FGS): from case reports to a call for concerted action against this neglected gynaecological diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.